Alemtuzumab for the treatment of multiple sclerosis
Ther Clin Risk Manag
.
2015 Mar 31:11:525-34.
doi: 10.2147/TCRM.S80112.
eCollection 2015.
Authors
Mark D Willis
1
,
Neil P Robertson
1
Affiliation
1
Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, UK.
PMID:
25848299
PMCID:
PMC4386803
DOI:
10.2147/TCRM.S80112
No abstract available
Keywords:
alemtuzumab; autoimmune disease; multiple sclerosis.
Publication types
Review
Grants and funding
MR/L010305/1/MRC_/Medical Research Council/United Kingdom